Margaret Dugan

Margaret Dugan

Chief Tech/Sci/R&D Officer at WHITEHAWK THERAPEUTICS, INC.

Net worth: 5 M $ as of 2026-06-29

69 year
Health Technology
Process Industries
Consumer Services

Profile

Margaret Han Dugan is currently an Independent Non-Executive Director at BeOne Medicines Ltd. since 2022 and will be Chief Medical Officer at Whitehawk Therapeutics, Inc. starting in 2025.
Former positions include Chief Medical Officer at Dracen Pharmaceuticals, Inc. from 2018 to 2023, Chief Medical Officer at Schrödinger, Inc., Senior VP & Head-Global Program Oncology at Novartis Pharmaceuticals Corp., Director-Oncology Clinical Research at Schering-Plough Corp., and Deputy Director-Clinical Research Oncology at Wyeth Holdings LLC.
Education includes undergraduate and doctorate degrees from New York University, conferred in 1977 and 1981 respectively.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-10 195,286 ( 0.01% ) 4 M $ 2026-06-29
2025-10-15 24,574 ( 0.04% ) 399 328 $ 2026-06-29
2026-05-13 19,132 ( 0.04% ) 87 625 $ 2026-06-29

Margaret Dugan active positions

CompaniesPositionStart
BEIGENE LTD Director/Board Member 2022-01-31
WHITEHAWK THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2025-11-30

Former positions of Margaret Dugan

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2023-01-31
SCHRÖDINGER, INC. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Margaret Dugan's experience

Training of Margaret Dugan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Process Industries

Health Technology

Consumer Services

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Margaret Dugan